|
RNF139 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.263900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.024160E-02 |
| Normal-vs-Stage2 |
8.761000E-01 |
| Normal-vs-Stage3 |
3.196200E-02 |
| Normal-vs-Stage4 |
1.234500E-02 |
| Stage1-vs-Stage2 |
4.250200E-02 |
| Stage1-vs-Stage3 |
8.797800E-01 |
| Stage1-vs-Stage4 |
6.442800E-01 |
| Stage2-vs-Stage3 |
6.412100E-02 |
| Stage2-vs-Stage4 |
4.091600E-02 |
| Stage3-vs-Stage4 |
6.162400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.637200E-03 |
| Normal-vs-AfricanAmerican |
3.738400E-02 |
| Normal-vs-Asian |
2.778000E-02 |
| Caucasian-vs-AfricanAmerican |
4.505600E-01 |
| Caucasian-vs-Asian |
8.482600E-01 |
| AfricanAmerican-vs-Asian |
4.569000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.740590E-01 |
| Normal-vs-Female |
6.421600E-03 |
| Male-vs-Female |
1.786210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.904600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.295500E-02 |
| Normal-vs-Age(61-80Yrs) |
7.873200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.410400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.918800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.117300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.472800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.663700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.947000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.964200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.954000E-01 |
| Classical-VS-Follicular |
1.84219972609867E-10 |
| Classical-VS-Other |
1.719810E-01 |
| Classical-VS-Normal |
3.372500E-04 |
| Tall-VS-Follicular |
1.24729999995132E-07 |
| Tall-VS-Other |
7.336400E-02 |
| Tall-VS-Normal |
6.763300E-04 |
| Follicular-VS-Other |
3.305800E-01 |
| Follicular-VS-Normal |
2.326400E-02 |
| Other-VS-Normal |
9.107200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.733600E-01 |
| Normal-vs-N1 |
1.195380E-01 |
| N0-vs-N1 |
1.240220E-01 |
|
|
